Weight Loss Plus Omega-3 Fatty Acids or Placebo in High Risk Women
Weight Loss Plus Omega-3 Fatty Acids or Placebo in High Risk Women
NCT ID: NCT02101970 Phase: NA Status: COMPLETED Enrollment: 46 Completion: 2018-08-27
Conditions
Breast Cancer
Interventions
Omega-3 Fatty Acids, Placebo Capsule, Diet and Exercise
Summary
The purpose of this study is to determine if high dose supplementation with the omega-3 fatty acids EPA and DHA, when added to a weight loss program, is well tolerated in the study population and if there is an increase in the favorable change in blood and tissue breast cancer risk factors when compared to weight loss alone.
Primary Outcome
Dropout rate